Mirela Dimitrova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mirela Dimitrova has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Christian Booz
Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
6 shared publications - Thomas Joseph Vogl
Medical University of Vienna, Center for Cancer Research
6 shared publications - Ibrahim Yel
Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
5 shared publications - Vitali Koch
Clinic for Radiology and Nuclear Medicine, University Hospital, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany
5 shared publications - Leona S. Alizadeh
Clinic for Radiology and Nuclear Medicine, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany
4 shared publications - Scherwin Mahmoudi
Goethe University Frankfurt, University Hospital Department of Radiology and Nuclear Medicine Frankfurt am Main Germany
4 shared publications
Latest Publications
- Open Access
- 28 August 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (17) , 2774
Plaque-Adapted Virtual Monoenergetic Image Selection for Carotid Plaque Visualization Using Photon-Counting CT
Objectives: The objective of this study was to evaluate the impact of virtual monoenergetic image (VMI) reconstructions derived from photon-counting computed tomography (PCCT) on the assessment of carotid arteries, with a focus on optimizing keV selection based on plaque composition. Methods: This retrospective study included 111 patients (mean age 80 ± 7.5 years; 64 men; 47 women) with carotid sclerosis who underwent PCCT between April 2022 and February 2023. One lesion was analyzed per patient, each containing both calcified and non-calcified components. Quantitative measurements were performed in calcified plaque across energy levels from 40 to 120 keV and comprised attenuation, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), corrected image noise (CIN) and artifact index (AIX). Two radiologists independently rated image quality, artifacts, and diagnostic assessability of both components using five-point scales. Results: Attenuation and CNR were highest at 40 to 50 keV, where CIN and AIX were also greatest. SNR followed a U-shaped course, lowest at 90 keV and highest at 110 to 120 keV, where intraluminal attenuation was too low for reliable luminal delineation. Reader ratings were highest at 40 to 50 keV for non-calcified components and at 70 to 80 keV for calcified plaque, with good interobserver agreement throughout (κ 0.74 to 0.92). After correction for multiple testing, adjacent energy levels were frequently indistinguishable. Conclusions: Optimal PCCT VMI energy levels depend on plaque composition. The findings support implementing standardized protocols with automatic dual-range reconstructions (40–50 keV and 70–80 keV) to enable efficient, individualized carotid plaque assessment in clinical practice.
- 28 August 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (17) , 2774
Open AccessPlaque-Adapted Virtual Monoenergetic Image Selection for Carotid Plaque Visualization Using Photon-Counting CT
Objectives: The objective of this study was to evaluate the impact of virtual monoenergetic image (VMI) reconstructions derived from photon-counting computed tomography (PCCT) on the assessment of carotid arteries, with a focus on optimizing keV selection based on plaque composition. Methods: This retrospective study included 111 patients (mean age 80 ± 7.5 years; 64 men; 47 women) with carotid sclerosis who underwent PCCT between April 2022 and February 2023. One lesion was analyzed per patient, each containing both calcified and non-calcified components. Quantitative measurements were performed in calcified plaque across energy levels from 40 to 120 keV and comprised attenuation, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), corrected image noise (CIN) and artifact index (AIX). Two radiologists independently rated image quality, artifacts, and diagnostic assessability of both components using five-point scales. Results: Attenuation and CNR were highest at 40 to 50 keV, where CIN and AIX were also greatest. SNR followed a U-shaped course, lowest at 90 keV and highest at 110 to 120 keV, where intraluminal attenuation was too low for reliable luminal delineation. Reader ratings were highest at 40 to 50 keV for non-calcified components and at 70 to 80 keV for calcified plaque, with good interobserver agreement throughout (κ 0.74 to 0.92). After correction for multiple testing, adjacent energy levels were frequently indistinguishable. Conclusions: Optimal PCCT VMI energy levels depend on plaque composition. The findings support implementing standardized protocols with automatic dual-range reconstructions (40–50 keV and 70–80 keV) to enable efficient, individualized carotid plaque assessment in clinical practice.
- Open Access
- 31 October 2024
- Published by University Library J. C. Senckenberg
Dual-Energy-CT-basierte Rho/Z-Karten zur Differenzierung von hypodensen Leberläsionen bei Patienten mit malignem Melanom
Zielsetzung: Das Ziel dieser Arbeit bestand darin, die diagnostische Genauigkeit von DECT-basierten Rho/Z-Karten zur Differenzierung von hypodensen Leberläsionen bei Patienten mit diagnostiziertem MM im Vergleich zu konventionellen HU-Wertmessungen zu untersuchen. Methoden: In diese retrospektive Studie wurden 73 Patienten (mittleres Alter 70 ± 13 Jahre; 43 Männer und 30 Frauen) mit MM eingeschlossen, die sich zwischen Dezember 2017 und Dezember 2021 einer Dual-Source-DECT der dritten Generation im Rahmen des Tumor-Stagings unterzogen hatten. Für diese Studie wurden Rho- und Z-Werte sowie die HU in hypodensen Leberläsionen gemessen. Die Werte wurden miteinander verglichen und die diagnostische Genauigkeit hinsichtlich der Differenzierung wurde mit Hilfe von Analysen der ROC-Kurve berechnet. Zusätzlich durchgeführte MRT-Untersuchungen oder Biopsien dienten als Referenzstandard. Ergebnisse: Insgesamt wurden 122 Läsionen (51 Metastasen und 71 Zysten) in kontrastverstärkten DECT-Bildern ausgewertet. Signifikante Unterschiede (p<0,001) zwischen den Messwerten für Melanommetastasen und gutartige Zysten wurden für die Z-Parameter (MD, -1,613 ± 0,0921, 110%) beobachtet, gefolgt von Rho (MD, -34,71 ± 3,318, 88%) und schließlich HU120kV (MD, -22,46 ± 3,007, 63%). Darüber hinaus ergaben die Messungen von Z und Rho einen höheren AUC-Wert (Z, 0,992; 95% CI, 0,956-1; Rho, 0,908; 95% CI, 0,842-0,953) im Vergleich zu HU120kV (0,829; 95% CI, 0,751-0,891) für die Läsionsdifferenzierung. Schlussfolgerung: Aus DECT abgeleitete Rho- und Z-Messungen ermöglichen bei Patienten mit MM eine im Vergleich zu konventionellen HU-Messungen bessere Unterscheidung zwischen Lebermetastasen und -zysten. Daher sollten in dieser Patientengruppe, sofern technisch verfügbar, Rho/Z-Karten und entsprechende Messungen bei hypodensen Leberläsionen eingesetzt werden.
- 31 October 2024
- Published by University Library J. C. Senckenberg
Open AccessDual-Energy-CT-basierte Rho/Z-Karten zur Differenzierung von hypodensen Leberläsionen bei Patienten mit malignem Melanom
Zielsetzung: Das Ziel dieser Arbeit bestand darin, die diagnostische Genauigkeit von DECT-basierten Rho/Z-Karten zur Differenzierung von hypodensen Leberläsionen bei Patienten mit diagnostiziertem MM im Vergleich zu konventionellen HU-Wertmessungen zu untersuchen. Methoden: In diese retrospektive Studie wurden 73 Patienten (mittleres Alter 70 ± 13 Jahre; 43 Männer und 30 Frauen) mit MM eingeschlossen, die sich zwischen Dezember 2017 und Dezember 2021 einer Dual-Source-DECT der dritten Generation im Rahmen des Tumor-Stagings unterzogen hatten. Für diese Studie wurden Rho- und Z-Werte sowie die HU in hypodensen Leberläsionen gemessen. Die Werte wurden miteinander verglichen und die diagnostische Genauigkeit hinsichtlich der Differenzierung wurde mit Hilfe von Analysen der ROC-Kurve berechnet. Zusätzlich durchgeführte MRT-Untersuchungen oder Biopsien dienten als Referenzstandard. Ergebnisse: Insgesamt wurden 122 Läsionen (51 Metastasen und 71 Zysten) in kontrastverstärkten DECT-Bildern ausgewertet. Signifikante Unterschiede (p<0,001) zwischen den Messwerten für Melanommetastasen und gutartige Zysten wurden für die Z-Parameter (MD, -1,613 ± 0,0921, 110%) beobachtet, gefolgt von Rho (MD, -34,71 ± 3,318, 88%) und schließlich HU120kV (MD, -22,46 ± 3,007, 63%). Darüber hinaus ergaben die Messungen von Z und Rho einen höheren AUC-Wert (Z, 0,992; 95% CI, 0,956-1; Rho, 0,908; 95% CI, 0,842-0,953) im Vergleich zu HU120kV (0,829; 95% CI, 0,751-0,891) für die Läsionsdifferenzierung. Schlussfolgerung: Aus DECT abgeleitete Rho- und Z-Messungen ermöglichen bei Patienten mit MM eine im Vergleich zu konventionellen HU-Messungen bessere Unterscheidung zwischen Lebermetastasen und -zysten. Daher sollten in dieser Patientengruppe, sofern technisch verfügbar, Rho/Z-Karten und entsprechende Messungen bei hypodensen Leberläsionen eingesetzt werden.
- Open Access
Therapy Response and Survival among Patients with Gynecologic Tumors Treated with Transarterial Chemoperfusion and Transarterial Chemoembolization
Background and Objectives: This study aimed to evaluate the tumor response relating to and survival benefit of transarterial chemoperfusion (TACP) and transarterial chemoembolization (TACE) in the treatment of patients with unresectable gynecologic tumors who are intolerant of or have a suboptimal response to chemotherapy and radiotherapy. Materials and Methods: Between January 2000 and October 2023, 75 patients diagnosed with gynecologic tumors underwent 213 TACP and 154 TACE procedures. Of these, 33 patients were treated with TACP, 20 were treated with TACE, and 22 received a combination of both therapies. A retrospective evaluation of local tumor response according to Response Evaluation Criteria in Solid Tumors (RECIST) was conducted, and survival rates were determined using the Kaplan–Meier estimator. Results: Of the total 75 patients, 50 (67%) maintained a stable course of disease until the completion of therapy, 10 (13%) had a partial response, 2 (3%) had a complete response following thermal ablation, and 13 (17%) experienced progression. Furthermore, a 6% reduction in the sum of the longest diameters and an 8% reduction in tumor volume were observed. The median overall survival was 16.15 months, while the median progression-free survival was 13.19 months. Conclusions: TACP and TACE are potential treatment options for local tumor control in patients with unresectable gynecologic tumors who are intolerant of or show a poor response to chemotherapy and radiotherapy. However, further investigation and adjustment of treatment protocols are required to improve therapy response and survival outcomes.
Open AccessTherapy Response and Survival among Patients with Gynecologic Tumors Treated with Transarterial Chemoperfusion and Transarterial Chemoembolization
Background and Objectives: This study aimed to evaluate the tumor response relating to and survival benefit of transarterial chemoperfusion (TACP) and transarterial chemoembolization (TACE) in the treatment of patients with unresectable gynecologic tumors who are intolerant of or have a suboptimal response to chemotherapy and radiotherapy. Materials and Methods: Between January 2000 and October 2023, 75 patients diagnosed with gynecologic tumors underwent 213 TACP and 154 TACE procedures. Of these, 33 patients were treated with TACP, 20 were treated with TACE, and 22 received a combination of both therapies. A retrospective evaluation of local tumor response according to Response Evaluation Criteria in Solid Tumors (RECIST) was conducted, and survival rates were determined using the Kaplan–Meier estimator. Results: Of the total 75 patients, 50 (67%) maintained a stable course of disease until the completion of therapy, 10 (13%) had a partial response, 2 (3%) had a complete response following thermal ablation, and 13 (17%) experienced progression. Furthermore, a 6% reduction in the sum of the longest diameters and an 8% reduction in tumor volume were observed. The median overall survival was 16.15 months, while the median progression-free survival was 13.19 months. Conclusions: TACP and TACE are potential treatment options for local tumor control in patients with unresectable gynecologic tumors who are intolerant of or show a poor response to chemotherapy and radiotherapy. However, further investigation and adjustment of treatment protocols are required to improve therapy response and survival outcomes.
- Open Access
- 30 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 742
Advancing Differentiation of Hepatic Metastases in Malignant Melanoma through Dual-Energy Computed Tomography Rho/Z Maps
Objectives: The aim of this study is to evaluate the diagnostic accuracy of dual-energy computed tomography (DECT)-based Rho/Z maps in differentiating between metastases and benign liver lesions in patients diagnosed with malignant melanoma compared to conventional CT value measurements. Methods: This retrospective study included 73 patients (mean age, 70 ± 13 years; 43 m/30 w) suffering from malignant melanoma who had undergone third-generation DECT as part of tumor staging between December 2017 and December 2021. For this study, we measured Rho (electron density) and Z (effective atomic number) values as well as Hounsfield units (HUs) in hypodense liver lesions. Values were compared, and diagnostic accuracy for differentiation was computed using receiver operating characteristic (ROC) curve analyses. Additional performed MRI or biopsies served as a standard of reference. Results: A total of 136 lesions (51 metastases, 71 cysts, and 14 hemangiomas) in contrast-enhanced DECT images were evaluated. The most notable discrepancy (p < 0.001) between measured values and the highest diagnostic accuracy for distinguishing melanoma metastases from benign cysts was observed for the Z (0.992; 95% CI, 0.956–1) parameters, followed by Rho (0.908; 95% CI, 0.842–0.953) and finally HU120kV (0.829; 95% CI, 0.751–0.891). Conversely, when discriminating between liver metastases and hemangiomas, the HU120kV parameters showed the most significant difference (p < 0.001) and yielded the highest values for diagnostic accuracy (0.859; 95% CI, 0.740–0.937), followed by the Z parameters (0.790; 95% CI, 0.681–0.876) and finally the Rho values (0.621; 95% CI, 0.501–0.730). Conclusions: Rho and Z measurements derived from DECT allow for improved differentiation of liver metastases and benign liver cysts in patients with malignant melanoma compared to conventional CT value measurements. In contrast, in differentiation between liver hemangiomas and metastases, Rho/Z maps show inferior diagnostic accuracy. Therefore, differentiation between these two lesions remains a challenge for CT imaging.
- 30 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 742
Open AccessAdvancing Differentiation of Hepatic Metastases in Malignant Melanoma through Dual-Energy Computed Tomography Rho/Z Maps
Objectives: The aim of this study is to evaluate the diagnostic accuracy of dual-energy computed tomography (DECT)-based Rho/Z maps in differentiating between metastases and benign liver lesions in patients diagnosed with malignant melanoma compared to conventional CT value measurements. Methods: This retrospective study included 73 patients (mean age, 70 ± 13 years; 43 m/30 w) suffering from malignant melanoma who had undergone third-generation DECT as part of tumor staging between December 2017 and December 2021. For this study, we measured Rho (electron density) and Z (effective atomic number) values as well as Hounsfield units (HUs) in hypodense liver lesions. Values were compared, and diagnostic accuracy for differentiation was computed using receiver operating characteristic (ROC) curve analyses. Additional performed MRI or biopsies served as a standard of reference. Results: A total of 136 lesions (51 metastases, 71 cysts, and 14 hemangiomas) in contrast-enhanced DECT images were evaluated. The most notable discrepancy (p < 0.001) between measured values and the highest diagnostic accuracy for distinguishing melanoma metastases from benign cysts was observed for the Z (0.992; 95% CI, 0.956–1) parameters, followed by Rho (0.908; 95% CI, 0.842–0.953) and finally HU120kV (0.829; 95% CI, 0.751–0.891). Conversely, when discriminating between liver metastases and hemangiomas, the HU120kV parameters showed the most significant difference (p < 0.001) and yielded the highest values for diagnostic accuracy (0.859; 95% CI, 0.740–0.937), followed by the Z parameters (0.790; 95% CI, 0.681–0.876) and finally the Rho values (0.621; 95% CI, 0.501–0.730). Conclusions: Rho and Z measurements derived from DECT allow for improved differentiation of liver metastases and benign liver cysts in patients with malignant melanoma compared to conventional CT value measurements. In contrast, in differentiation between liver hemangiomas and metastases, Rho/Z maps show inferior diagnostic accuracy. Therefore, differentiation between these two lesions remains a challenge for CT imaging.
- Open Access
- 26 February 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 496
Dual-Energy CT Iodine Uptake of Head and Neck: Definition of Reference Values in a Big Data Cohort
Background: Despite a considerable amount of literature on dual-energy CT (DECT) iodine uptake of the head and neck, the physiologic iodine uptake of this region has not been defined yet. This study aims to establish reference values for the iodine uptake of healthy organs to facilitate clinical application. Methods: Consecutive venous DECT scans of the head and neck were reviewed, and unremarkable exams were included (n = 617). A total of 35 region of interest measurements were performed in 16 anatomical regions. Iodine uptake was compared among different organs/tissues and subgroup analysis was performed (male (n = 403) vs. female (n = 214); young (n = 207) vs. middle-aged (n = 206) vs. old (n = 204); and normal weight (n = 314) vs. overweight (n = 196) vs. obese (n = 107)). Results: Overall mean iodine uptake values ranged between 0.5 and 9.4 mg/mL. Women showed higher iodine concentrations in the cervical vessels and higher uptake for the parotid gland, masseter muscle, submandibular glands, sublingual glands, palatine tonsils, tongue body, thyroid gland, and the sternocleidomastoid muscle than men (p ≤ 0.04). With increasing age, intravascular iodine concentrations increased as well as iodine uptake for cerebellum and thyroid gland, while values for the tongue and palatine tonsils were lower compared to younger subjects (p ≤ 0.03). Iodine concentrations for parotid glands and sternocleidomastoid muscles decreased with a higher BMI (p ≤ 0.004), while normal-weighted patients showed higher iodine values inside the jugular veins, other cervical glands, and tonsils versus patients with a higher BMI (p ≤ 0.04). Conclusion: physiologic iodine uptake values of cervical organs and tissues show gender-, age-, and BMI-related differences, which should be considered in the clinical routine of head and neck DECT.
- 26 February 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 496
Open AccessDual-Energy CT Iodine Uptake of Head and Neck: Definition of Reference Values in a Big Data Cohort
Background: Despite a considerable amount of literature on dual-energy CT (DECT) iodine uptake of the head and neck, the physiologic iodine uptake of this region has not been defined yet. This study aims to establish reference values for the iodine uptake of healthy organs to facilitate clinical application. Methods: Consecutive venous DECT scans of the head and neck were reviewed, and unremarkable exams were included (n = 617). A total of 35 region of interest measurements were performed in 16 anatomical regions. Iodine uptake was compared among different organs/tissues and subgroup analysis was performed (male (n = 403) vs. female (n = 214); young (n = 207) vs. middle-aged (n = 206) vs. old (n = 204); and normal weight (n = 314) vs. overweight (n = 196) vs. obese (n = 107)). Results: Overall mean iodine uptake values ranged between 0.5 and 9.4 mg/mL. Women showed higher iodine concentrations in the cervical vessels and higher uptake for the parotid gland, masseter muscle, submandibular glands, sublingual glands, palatine tonsils, tongue body, thyroid gland, and the sternocleidomastoid muscle than men (p ≤ 0.04). With increasing age, intravascular iodine concentrations increased as well as iodine uptake for cerebellum and thyroid gland, while values for the tongue and palatine tonsils were lower compared to younger subjects (p ≤ 0.03). Iodine concentrations for parotid glands and sternocleidomastoid muscles decreased with a higher BMI (p ≤ 0.004), while normal-weighted patients showed higher iodine values inside the jugular veins, other cervical glands, and tonsils versus patients with a higher BMI (p ≤ 0.04). Conclusion: physiologic iodine uptake values of cervical organs and tissues show gender-, age-, and BMI-related differences, which should be considered in the clinical routine of head and neck DECT.
- Open Access
- 5 February 2024
- Published by MDPI AG in Preprints.org
Dual-Energy CT Iodine Uptake of Head and Neck: Definition of Reference Values in a Big Data Cohort
Purpose Despite a considerable amount of literature on dual-energy-CT(DECT) iodine uptake of the head and neck, the physiologic iodine uptake of this region has not been defined yet. This study aims to establish reference values for the iodine uptake of healthy organs to facilitate clinical application. Material and Methods: Consecutive venous DECT scans of head and neck were reviewed, and unremarkable exams were included (n=617). 35 region of interest measurements were performed in 16 anatomical regions. Iodine uptake was compared among different organs/tissues and subgroup analysis was performed (male [n=403] vs female [n=214]; young [n=207] vs middle-aged [n=206] vs old [n=204]; normal weight [n=314] vs overweight [n=196] vs obese [n=107]]). Results: Overall mean iodine uptake values ranged between 0.5 and 9.4mg/ml. Women showed higher iodine concentration in the cervical vessels and higher uptake for the parotid gland, masseter muscle, submandibular glands, sublingual glands, palatine tonsils, tongue body, thyroid gland, and the sternocleidomastoid muscle than men (p0.04). With increasing age, intravascular iodine concentrations increased as well as iodine uptake for cerebellum and thyroid gland, while values for tongue and palatine tonsils were lower compared to younger subjects (p0.03). Iodine concentrations for parotid glands and sternocleidomastoid muscles decreased with higher BMI (p0.004), while normal-weighted patients showed higher iodine values inside the jugular veins, other cervical glands, and tonsils versus patients with higher BMI (p0.04). Conclusion: Physiologic iodine uptake values of cervical organs and tissues show gender-, age-, and BMI-related differences, which should be considered in clinical routine of head and neck DECT.
- 5 February 2024
- Published by MDPI AG in Preprints.org
Open AccessDual-Energy CT Iodine Uptake of Head and Neck: Definition of Reference Values in a Big Data Cohort
Purpose Despite a considerable amount of literature on dual-energy-CT(DECT) iodine uptake of the head and neck, the physiologic iodine uptake of this region has not been defined yet. This study aims to establish reference values for the iodine uptake of healthy organs to facilitate clinical application. Material and Methods: Consecutive venous DECT scans of head and neck were reviewed, and unremarkable exams were included (n=617). 35 region of interest measurements were performed in 16 anatomical regions. Iodine uptake was compared among different organs/tissues and subgroup analysis was performed (male [n=403] vs female [n=214]; young [n=207] vs middle-aged [n=206] vs old [n=204]; normal weight [n=314] vs overweight [n=196] vs obese [n=107]]). Results: Overall mean iodine uptake values ranged between 0.5 and 9.4mg/ml. Women showed higher iodine concentration in the cervical vessels and higher uptake for the parotid gland, masseter muscle, submandibular glands, sublingual glands, palatine tonsils, tongue body, thyroid gland, and the sternocleidomastoid muscle than men (p0.04). With increasing age, intravascular iodine concentrations increased as well as iodine uptake for cerebellum and thyroid gland, while values for tongue and palatine tonsils were lower compared to younger subjects (p0.03). Iodine concentrations for parotid glands and sternocleidomastoid muscles decreased with higher BMI (p0.004), while normal-weighted patients showed higher iodine values inside the jugular veins, other cervical glands, and tonsils versus patients with higher BMI (p0.04). Conclusion: Physiologic iodine uptake values of cervical organs and tissues show gender-, age-, and BMI-related differences, which should be considered in clinical routine of head and neck DECT.
- 1 June 2022
- Published by Elsevier in Academic Radiology
- Vol. 29 (6) , 880-887
Impact of Intravenously Injected Contrast Agent on Bone Mineral Density Measurement in Dual-Source Dual-Energy CT
- 1 June 2022
- Published by Elsevier in Academic Radiology
- Vol. 29 (6) , 880-887
Impact of Intravenously Injected Contrast Agent on Bone Mineral Density Measurement in Dual-Source Dual-Energy CT